The US Food and Drug Administration (FDA) has accepted Bristol Myers Squibb’s (BMS) supplemental biologics licence ...
Increasing numbers of women are getting additional screenings to rule out breast cancer. But such screenings cost money, out ...
China’s DeepSeek shocked the world by delivering unexpected innovation at an unbelievable price. But this disruptive trend ...
There are now many colorectal cancer screening options, but gastroenterologists say a colonoscopy is still necessary.
Dr. Gabriel A. Brooks discusses what DPD deficiency is and why it is important for patients with cancer receiving 5-FU or ...
A new assay rapidly detected pancreatic ductal adenocarcinoma and differentiated it from noncancer pancreatic diseases by ...
Bristol Myers said about 5% to 7% of people with metastatic colorectal cancer have microsatellite instability-high or mismatch-repair-deficient tumors, adding that these patients are less likely to ...
The FDA accepted for priority review a supplemental Biologics License Application for Keytruda for resectable locally ...
Designation applies to the treatment of adult patients with recurrent or metastatic head and neck squamous cell carcinoma ...